Private Advisor Group, LLC Oramed Pharmaceuticals Inc. Transaction History

Private Advisor Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 18, 2023	BUY	$5.88 - $12.03 $69,348 - $141,881	11,794 New	11,794 $0
Q2 2022 Jul 13, 2022	SELL	$3.72 - $9.0 $47,437 - $114,768	-12,752 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$12.98 - $29.75 $7,463 - $17,106	575 Added 4.72%	12,752 $182,000
Q3 2021 Oct 14, 2021	BUY	$12.13 - $23.82 $8,078 - $15,864	666 Added 5.79%	12,177 $268,000
Q2 2021 Aug 12, 2021	BUY	$8.34 - $14.59 $96,001 - $167,945	11,511 New	11,511 $154,000

7.4M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $90.9M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Advisor Group, LLC with notifications on news.